BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29523771)

  • 1. Glycobiology of syndecan-1 in bacterial infections.
    Aquino RS; Teng YH; Park PW
    Biochem Soc Trans; 2018 Apr; 46(2):371-377. PubMed ID: 29523771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils.
    Jinno A; Hayashida A; Jenkinson HF; Park PW
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
    Yang N; Friedl A
    PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection.
    Hayashida A; Amano S; Gallo RL; Linhardt RJ; Liu J; Park PW
    J Biol Chem; 2015 Jun; 290(26):16157-67. PubMed ID: 25931123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense.
    Hayashida A; Amano S; Park PW
    J Biol Chem; 2011 Feb; 286(5):3288-97. PubMed ID: 21127056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host syndecan-1 promotes listeriosis by inhibiting intravascular neutrophil extracellular traps.
    Aquino RS; Hayashida A; Park PW
    PLoS Pathog; 2020 May; 16(5):e1008497. PubMed ID: 32453780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.
    Zhang Y; Wang Z; Liu J; Zhang S; Fei J; Li J; Zhang T; Wang J; Park PW; Chen Y
    J Cell Mol Med; 2017 Jan; 21(1):13-25. PubMed ID: 27558380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity.
    Zhang Y; Wang N; Raab RW; McKown RL; Irwin JA; Kwon I; van Kuppevelt TH; Laurie GW
    J Biol Chem; 2013 Apr; 288(17):12090-101. PubMed ID: 23504321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1.
    Ebong EE; Lopez-Quintero SV; Rizzo V; Spray DC; Tarbell JM
    Integr Biol (Camb); 2014 Mar; 6(3):338-47. PubMed ID: 24480876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
    Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
    Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells.
    Kumar-Singh A; Shrinet J; Parniewska MM; Fuxe J; Dobra K; Hjerpe A
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
    Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
    Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dually modified transmembrane proteoglycans in development and disease.
    Jenkins LM; Horst B; Lancaster CL; Mythreye K
    Cytokine Growth Factor Rev; 2018 Feb; 39():124-136. PubMed ID: 29291930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 and Its Expanding List of Contacts.
    Stepp MA; Pal-Ghosh S; Tadvalkar G; Pajoohesh-Ganji A
    Adv Wound Care (New Rochelle); 2015 Apr; 4(4):235-249. PubMed ID: 25945286
    [No Abstract]   [Full Text] [Related]  

  • 15. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
    Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
    J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies.
    Gharbaran R
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):1-17. PubMed ID: 25563413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate chains of syndecan-1 regulate ectodomain shedding.
    Ramani VC; Pruett PS; Thompson CA; DeLucas LD; Sanderson RD
    J Biol Chem; 2012 Mar; 287(13):9952-9961. PubMed ID: 22298773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.
    Shi Q; Jiang J; Luo G
    J Virol; 2013 Jun; 87(12):6866-75. PubMed ID: 23576506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III Contributes to the Protective Effects of Fresh Frozen Plasma Following Hemorrhagic Shock by Preventing Syndecan-1 Shedding and Endothelial Barrier Disruption.
    Lopez E; Peng Z; Kozar RA; Cao Y; Ko TC; Wade CE; Cardenas JC
    Shock; 2020 Feb; 53(2):156-163. PubMed ID: 31389906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
    Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
    Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.